According to Gram Research analysis, a specific gut bacteria called Lactobacillus gasseri reduced diabetes development in mice by limiting a nutrient called methionine, which normally keeps immune cells in a heightened inflammatory state. In the study, mice receiving this bacteria developed diabetes significantly less often and showed better blood sugar control and insulin sensitivity compared to untreated mice. However, this is early-stage research in animals, and human studies are needed before this bacteria can be recommended as a diabetes treatment.

Scientists discovered that a specific type of gut bacteria called Lactobacillus gasseri may help prevent type 2 diabetes by changing how immune cells behave. In a study using mice prone to diabetes, this bacteria reduced diabetes development and improved how the body handles blood sugar and fat. The bacteria works by limiting a nutrient called methionine, which normally triggers immune cells to stay in a heightened alert state. Interestingly, the diabetes drug metformin appeared to help this beneficial bacteria grow in the intestines. While these findings are promising, researchers emphasize this is early-stage research that needs human testing before people should consider it a diabetes treatment.

Key Statistics

A 2026 exploratory study in mice found that Lactobacillus gasseri significantly reduced diabetes incidence and improved glucose tolerance and insulin sensitivity in mice fed a high-fat diet, suggesting the bacteria may work by limiting methionine availability to immune cells.

Research published in 2026 showed that Lactobacillus gasseri reduced IL-1 beta-mediated inflammation in immune cells by decreasing methionine-dependent epigenetic changes, a mechanism that could explain how this bacteria might help prevent type 2 diabetes.

A 2026 study demonstrated that the diabetes drug metformin enhanced intestinal colonization of Lactobacillus gasseri and improved mucus barrier integrity in mice, suggesting a potential synergy between the drug and this beneficial bacteria.

The Quick Take

  • What they studied: Whether a specific gut bacteria called Lactobacillus gasseri could prevent or reduce type 2 diabetes by changing how immune cells work, and how the diabetes drug metformin affects this bacteria.
  • Who participated: Laboratory mice bred to be prone to diabetes. Researchers gave some mice a high-fat diet plus a chemical that damages the pancreas to create diabetes-like conditions. They also studied immune cells from mouse bone marrow in laboratory dishes.
  • Key finding: Mice treated with Lactobacillus gasseri developed diabetes less often, had better blood sugar control, and showed less inflammation compared to untreated mice. The bacteria appeared to work by reducing a nutrient called methionine that normally keeps immune cells in a heightened alert state.
  • What it means for you: This research suggests probiotics containing Lactobacillus gasseri might someday help prevent or manage type 2 diabetes, but this is very early research. Do not start taking this bacteria as a diabetes treatment yet. Talk to your doctor before making any changes to diabetes management. Human studies are needed first.

The Research Details

Researchers created mice that were prone to developing type 2 diabetes by feeding them a high-fat diet and giving them a chemical that damages insulin-producing cells in the pancreas. Some mice received Lactobacillus gasseri bacteria while others did not, allowing researchers to compare outcomes. They measured blood sugar levels, insulin sensitivity, fat levels, and pancreas damage. They also studied immune cells called macrophages in laboratory dishes to understand exactly how the bacteria might work at the cellular level. The researchers examined whether limiting a nutrient called methionine could explain the bacteria’s effects, and they tested whether the diabetes drug metformin influenced how well this bacteria colonized the intestines.

This research approach matters because it combines whole-body studies in living animals with detailed laboratory studies of individual cells and molecules. This helps researchers understand not just whether something works, but how it works. Understanding the mechanism (the ‘why’) is crucial before testing in humans. The study also examined how an existing diabetes drug might work together with probiotics, which could lead to better combination treatments.

This is exploratory research in mice, which is an important early step but not proof that the same effects occur in humans. The study was well-designed with appropriate control groups to separate the effects of diet, the diabetes-inducing chemical, and the bacteria itself. The researchers used multiple measurement methods to verify their findings. However, the study did not test whether combining the bacteria with metformin in living animals would produce better results than either treatment alone, which limits conclusions about combination therapy. The findings are interesting but preliminary.

What the Results Show

Mice receiving Lactobacillus gasseri showed significantly lower rates of developing diabetes compared to untreated mice. These treated mice also had better blood sugar control and improved insulin sensitivity, meaning their bodies responded better to insulin. The bacteria reduced harmful fat levels in the blood and decreased damage to the pancreas, the organ that produces insulin. Importantly, the bacteria appeared to reduce chronic inflammation, which is a key problem in type 2 diabetes. The treated mice showed lower levels of inflammatory molecules, particularly a protein called IL-1 beta that drives inflammation. These improvements occurred without any obvious side effects in the mice.

The researchers found that the bacteria improved the integrity of the intestinal barrier, the protective lining of the gut. This is important because a damaged intestinal barrier can allow harmful substances to enter the bloodstream and trigger inflammation. The bacteria also enhanced the production of protective mucus in the intestines. When researchers studied immune cells in laboratory dishes, they found that limiting methionine (a nutrient) reduced the cells’ inflammatory response, suggesting this is how the bacteria works. Additionally, the diabetes drug metformin appeared to help Lactobacillus gasseri colonize the intestines more effectively, though the study did not test whether this combination produced better results in living animals.

This research builds on growing evidence that gut bacteria influence diabetes risk and that probiotics may have therapeutic potential. Previous studies suggested that certain bacteria can reduce inflammation and improve metabolic health. This study adds a new mechanism: the idea that bacteria can control how much of a nutrient called methionine is available, which in turn affects how immune cells are ’trained’ to respond. The connection between methionine, epigenetic changes (changes in how genes are expressed), and immune cell memory is relatively new. The finding that metformin might enhance beneficial bacteria growth is also novel and could explain part of why metformin works so well for diabetes.

This study used mice, not humans, so results may not directly apply to people. The sample size and specific number of mice used were not clearly reported. The study did not test whether combining Lactobacillus gasseri with metformin in living animals would produce better results than either treatment alone, so claims about combination therapy are speculative. The research is exploratory, meaning it identifies promising leads but does not prove these bacteria will work as a diabetes treatment in humans. The study did not examine whether the bacteria would work in people who already have diabetes or only in prevention. Long-term safety and effectiveness in humans remain unknown.

The Bottom Line

Based on this research, Lactobacillus gasseri shows promise as a potential diabetes prevention strategy, but human studies are needed before recommendations can be made. Current evidence is moderate in strength because it comes from animal studies. Do not start taking Lactobacillus gasseri supplements specifically for diabetes prevention based on this research alone. If you are at risk for type 2 diabetes, focus on proven strategies: maintain a healthy weight, exercise regularly, eat a balanced diet, and work with your doctor on screening and prevention. If you are interested in probiotics, discuss options with your healthcare provider.

This research is most relevant to people at high risk for type 2 diabetes, including those who are overweight, have a family history of diabetes, or have prediabetes. It may also interest people already managing type 2 diabetes who are looking for additional strategies. People taking metformin for diabetes should not change their treatment based on this research. Healthcare providers and researchers studying diabetes prevention and the role of gut bacteria should pay attention to these findings. People with compromised immune systems should consult their doctor before taking any probiotics.

In the mice studied, improvements in blood sugar control and diabetes prevention appeared within the timeframe of the experiment, but the exact timeline was not clearly specified. If similar bacteria were tested in humans, benefits would likely take weeks to months to appear, as changes in gut bacteria colonization and immune system function occur gradually. Do not expect immediate results from any probiotic intervention.

Frequently Asked Questions

Can Lactobacillus gasseri prevent type 2 diabetes?

Mouse studies show Lactobacillus gasseri reduced diabetes development and improved blood sugar control, but human research is needed. This is promising early evidence, not proof. Talk to your doctor before using probiotics for diabetes prevention.

How does Lactobacillus gasseri help with diabetes?

The bacteria appears to limit methionine, a nutrient that normally keeps immune cells in a heightened inflammatory state. By reducing methionine availability, the bacteria may calm chronic inflammation that drives type 2 diabetes development.

Should I take Lactobacillus gasseri if I have prediabetes?

Not yet based on this research alone. While mouse studies are encouraging, human studies are needed first. Focus on proven strategies: weight management, regular exercise, healthy eating, and regular checkups with your doctor.

Does metformin work better with Lactobacillus gasseri?

The study found metformin enhanced this bacteria’s growth in mouse intestines, but researchers did not test whether combining them in living animals produced better results. This is speculative and requires human research.

What are the risks of taking Lactobacillus gasseri probiotics?

Probiotics are generally safe for most people, but those with compromised immune systems should consult their doctor first. This specific bacteria has not been tested for long-term safety in humans, so risks remain unknown.

Want to Apply This Research?

  • Track daily probiotic intake (type, brand, and dose) alongside fasting blood sugar readings if you have prediabetes or diabetes. Record any changes in energy levels, digestion, or inflammation markers over 8 to 12 weeks to identify patterns.
  • If your doctor approves, add a probiotic containing Lactobacillus gasseri to your daily routine at the same time each day. Pair this with tracking your diet quality, exercise minutes, and how you feel. Use the app to log which foods you eat and note any digestive changes.
  • Monitor blood sugar levels regularly if you have diabetes or prediabetes. Track your weight, waist circumference, and energy levels monthly. Note any changes in digestion, bloating, or inflammation. Share this data with your healthcare provider at regular checkups to assess whether any probiotic intervention is helping. Do not rely on subjective feelings alone; objective measurements matter.

This research is preliminary and conducted in mice, not humans. Lactobacillus gasseri should not be used as a diabetes treatment or prevention strategy without consulting your healthcare provider. If you have type 2 diabetes or prediabetes, continue following your doctor’s treatment plan and do not make changes based on this research alone. Probiotics are not regulated as strictly as medications and may not be appropriate for people with compromised immune systems. Always discuss any new supplements or dietary changes with your healthcare provider before starting them. This article is for educational purposes and does not constitute medical advice.

This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.

Source: Lactobacillus gasseri suppresses methionine-driven epigenetic programming of trained immunity-like priming to attenuate metabolic dysfunction. , International immunopharmacology (2026). PubMed 42843317 | DOI
Topics
Lactobacillus gasseri type 2 diabetes prevention gut bacteria probiotics methionine metabolism immune system inflammation metformin diabetes drug intestinal barrier health metabolic dysfunction